Literature DB >> 23450747

Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping.

Jeremy Brooks1, Christopher M Kramer, Michael Salerno.   

Abstract

PURPOSE: To perform myocardial T1 mapping pre- and post-gadolinium (Gd) administration and determine the volume of distribution of Gd (VdGd ) in patients with cardiac amyloidosis to assess extracellular space expansion from amyloid protein deposition.
MATERIALS AND METHODS: T1 mapping was performed before contrast and 20 minutes following bolus administration of 0.15 mmol/kg of gadopentetate dimeglumine (Magnevist) in five subjects with cardiac amyloidosis and in eight healthy volunteers using previously validated 3-5 Modified Look-Locker Inversion (MOLLI) pulse sequence. The partition coefficient (λ) and VdGd were determined and compared between groups.
RESULTS: Before contrast the T1 of the blood and myocardium are longer in amyloidosis as compared to controls (1665 vs. 1509 msec; P = 0.03 and 1144 vs. 963 msec; P < 0.001, respectively). Postcontrast blood T1 was also significantly longer in amyloidosis (486 vs. 408 msec; P = 0.003) with a trend towards shorter T1 in the myocardium (503 vs. 544 msec; P = 0.15). The VdGd was 83% higher in amyloidosis than in controls (0.51 vs. 0.28; P = 0.005).
CONCLUSION: Myocardial VdGd is markedly increased in cardiac amyloidosis, reflecting the increased extracellular space occupied by amyloid proteins. The precontrast T1 of blood and myocardium are increased in amyloidosis extending diagnostic utility in patients who cannot receive Gd.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  T1 mapping; amyloidosis; cardiac MRI; modified Look-Locker; volume of distribution

Mesh:

Substances:

Year:  2013        PMID: 23450747      PMCID: PMC3855558          DOI: 10.1002/jmri.24078

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  14 in total

1.  T1 mapping shows increased extracellular matrix size in the myocardium due to amyloid depositions.

Authors:  Lourens F H J Robbers; Emma N Baars; Wessel P Brouwer; Aernout M Beek; Mark B M Hofman; Hans W M Niessen; Albert C van Rossum; C Bogdan Marcu
Journal:  Circ Cardiovasc Imaging       Date:  2012-05-01       Impact factor: 7.792

2.  Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.

Authors:  S W Dubrey; K Cha; M Skinner; M LaValley; R H Falk
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

3.  Advances in Cardiovascular MRI for Diagnostics: Applications in Coronary Artery Disease and Cardiomyopathies.

Authors:  Michael Salerno; Christopher M Kramer
Journal:  Expert Opin Med Diagn       Date:  2009-11-01

4.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

5.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

6.  Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.

Authors:  Bethany A Austin; W H Wilson Tang; E Rene Rodriguez; Carmela Tan; Scott D Flamm; David O Taylor; Randall C Starling; Milind Y Desai
Journal:  JACC Cardiovasc Imaging       Date:  2009-12

Review 7.  Evaluation and management of the cardiac amyloidosis.

Authors:  Joseph B Selvanayagam; Philip N Hawkins; Biju Paul; Saul G Myerson; Stefan Neubauer
Journal:  J Am Coll Cardiol       Date:  2007-11-13       Impact factor: 24.094

Review 8.  Primary systemic amyloidosis.

Authors:  Morie A Gertz; S Vincent Rajkumar
Journal:  Curr Treat Options Oncol       Date:  2002-06

9.  Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T1 mapping.

Authors:  Michael Salerno; Rajesh Janardhanan; Ronny S Jiji; Jeremy Brooks; Nebiyu Adenaw; Bhairav Mehta; Yang Yang; Patrick Antkowiak; Christopher M Kramer; Frederick H Epstein
Journal:  J Magn Reson Imaging       Date:  2012-11-29       Impact factor: 4.813

10.  Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.

Authors:  Alicia M Maceira; Sanjay K Prasad; Philip N Hawkins; Michael Roughton; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2008-11-25       Impact factor: 5.364

View more
  25 in total

1.  The case for CMR.

Authors:  Peter W Shaw; Christopher M Kramer
Journal:  J Nucl Cardiol       Date:  2015-07-08       Impact factor: 5.952

2.  Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis.

Authors:  Francesco Sardanelli; Simone Schiaffino; Moreno Zanardo; Francesco Secchi; Paola Maria Cannaò; Federico Ambrogi; Giovanni Di Leo
Journal:  Eur Radiol       Date:  2019-05-02       Impact factor: 5.315

3.  Novel cardiac magnetic resonance biomarkers: native T1 and extracellular volume myocardial mapping.

Authors:  Paola Maria Cannaò; Luisa Altabella; Marcello Petrini; Marco Alì; Francesco Secchi; Francesco Sardanelli
Journal:  Eur Heart J Suppl       Date:  2016-04-29       Impact factor: 1.803

4.  Role of Cardiac MR Imaging in Cardiomyopathies.

Authors:  Christopher M Kramer
Journal:  J Nucl Med       Date:  2015-06       Impact factor: 10.057

5.  Myocardial strain pattern in patients with cardiac amyloidosis secondary to multiple myeloma: a cardiac MRI feature tracking study.

Authors:  Sabha Bhatti; Srikanth Vallurupalli; Stephanie Ambach; Adam Magier; Evan Watts; Vien Truong; Abdul Hakeem; Wojciech Mazur
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-14       Impact factor: 2.357

Review 6.  Cardiac MRI: a central prognostic tool in myocardial fibrosis.

Authors:  Bharath Ambale-Venkatesh; João A C Lima
Journal:  Nat Rev Cardiol       Date:  2014-10-28       Impact factor: 32.419

7.  Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.

Authors:  Fabian aus dem Siepen; Sebastian J Buss; Florian Andre; Sebastian Seitz; Evangelos Giannitsis; Henning Steen; Hugo A Katus; Arnt V Kristen
Journal:  Clin Res Cardiol       Date:  2015-02-18       Impact factor: 5.460

8.  Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis.

Authors:  Jonathan A Pan; Matthew J Kerwin; Michael Salerno
Journal:  JACC Cardiovasc Imaging       Date:  2020-06

Review 9.  Myocardial T1 and ECV Measurement: Underlying Concepts and Technical Considerations.

Authors:  Austin A Robinson; Kelvin Chow; Michael Salerno
Journal:  JACC Cardiovasc Imaging       Date:  2019-09-18

Review 10.  Use of Noninvasive Imaging in Cardiac Amyloidosis.

Authors:  Raymundo Alain Quintana-Quezada; Syed Wamique Yusuf; Jose Banchs
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.